Who is eligible for clinical trial NCT03092011?

Participants must meet the protocol's inclusion criteria for Neonatal Abstinence Syndrome. The stated age range is Not specified to 10 Days. Confirm all requirements with the study coordinator.

Does clinical trial NCT03092011 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2024-10-09

Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy (NCT03092011)

🔵 Active, Not Recruiting Phase4 💊 Investigational Drug / Biologic Sponsor: The Cooper Health System

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this study is to show non-inferiority between two medications used for medical treatment of withdrawal seen in Neonatal Abstinence Syndrome (NAS), Clonidine and Morphine Sulfate (used in routine care) on length of treatment for NAS .

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (5 items).

Location: Cooper University Hospital — Camden, New Jersey

Age range: Not specified to 10 Days

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Born at Cooper University Hospital
Greater than or equal to 35 weeks gestation age
Admitted to the NICU or Transitional nursery
Mothers admitted to using illicit substances or prescription medications (which can result in withdrawal symptoms) while pregnant and/or had a positive urine drug screen during pregnancy.
Babies being started on medication to control withdrawal symptoms of NAS.
No congenital anomalies or neurologic condition (i.e. hypoxic-ischemic encephalopathy, seizures, meningitis etc.)

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Premature infants \<35 week gestational age
Infants with major congenital abnormalities
Blood pressure instability
Major medical conditions

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Cooper University Hospital — Camden, New Jersey

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Neonatal Abstinence Syndrome

The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program — Edmonton, Alberta
Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women — Spokane, Washington

Explore by condition: All Neonatal Abstinence Syndrome clinical trials

💡 How to Participate

Check the checklist above to see if you may qualify.
Review the official NIH record below to find the coordinating site.
Ask about the visit schedule, what is covered at no cost, and any travel support.
Confirm with your own doctor before making a decision.

🏛️ View Official NIH Record ↗